Tailor-Made Pentablock Copolymer Based Formulation for Sustained Ocular Delivery of Protein Therapeutics

Table 2

Characterization of FITC-BSA and IgG-loaded NPs.

Proteins	Copolymers	Entrapment efficiency (%)	Loading (%)	Particle size	Polydispersity
FITC-BSA	PB-A	34.98±3.73	5.02±0.39	351.5±30.7	0.286
	PB-B	69.54±6.23	5.42±0.46	323.1±24.7	0.280
IgG	PB-A	40.51±3.46	6.31±0.27	367.9±11.9	0.305
	PB-B	70.06±4.12	6.07±0.31	346.4±3.9	0.273
Bevacizumab	PB-B	67.34±3.28	6.12±0.22	337.8±18.4	0.246

Results are described in mean ± SD, 𝑛=3.